This report signifies that the Asia-Pacific eubiotics market is estimated to witness growth at a compound annual growth rate of 7.98% during the considered period 2021-2028. South Korea, Australia & New Zealand, China, India, Japan, ASEAN countries, and Rest of Asia-Pacific form the market in this region.
Classical swine fever, also known as swine cholera, a deadly pig illness, affected Japan in 2019. Moreover, the Tokyo Ministry of Agriculture, Forestry, and Fisheries reported several outbreaks of this disease to the World Animal Health Organization in the past few years. Since eubiotics help boost the immune systems of animals, their use can prevent such an epidemic. Therefore, the outbreak of animal diseases significantly supplements the progression of the eubiotics market across Japan.
On the other hand, in India, livestock plays a key role in rural areas. Thus, the outbreak of various diseases, including avian flu, encourages states to increase control measures. Furthermore, the bird flu outbreak affected more than 14 states and union territories. These outbreaks enhance the need to maintain animal health and safety, increasing the need for eubiotics to a large extent.
Furthermore, antimicrobial resistance caused by improper use of antibiotics is of major concern in the country. In this regard, the Indian government took measures to prohibit the production, sale, and distribution of colistin, an antibiotic, for food-producing animals. Therefore, all these factors are widening the scope of the eubiotics market across India.
Competitive Outlook
The leading companies in the eubiotics market include Archer Daniels Midland, Behn Meyer Group, Kemin Industries Inc, Beneo GmbH, Novus International Inc, CHR Hansen Holding AS, and Anpario Plc.
Table of Contents
1. Asia-Pacific Eubiotics Market - Summary2. Industry Outlook
2.1. Impact of Covid-19 on Eubiotics Market
2.2. Key Insights
2.2.1. Eubiotics as An Alternative to Antibiotics
2.2.2. Applications of Eubiotics in Calves' Gut Health
2.2.3. Developing Food Additive Platform Based on Grains
2.3. Porter’S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Mergers & Acquisitions
2.6.2. Contracts & Agreements
2.6.3. Product Launches
2.6.4. Expansions
2.7. Market Drivers
2.7.1. Rising Meat Consumption
2.7.2. Growing Awareness and Concerns Regarding Animal Health
2.7.3. Increasing Demand for Manufactured Feeds
2.8. Market Challenges
2.8.1. Unawareness About Eubiotics
2.9. Market Opportunities
2.9.1. Government Support for Eubiotics Use
2.9.2. Probiotics Spray Coatings
2.9.3. Essential Oils for Necrotic Enteritis
3. Asia-Pacific Eubiotics Market Outlook - by Type
3.1. Probiotics
3.2. Organic Acid
3.3. Prebiotics
3.4. Essential Oils
4. Asia-Pacific Eubiotics Market Outlook - by Form
4.1. Dry
4.2. Liquid
5. Asia-Pacific Eubiotics Market Outlook - by Livestock
5.1. Swine
5.2. Poultry
5.3. Ruminants
5.4. Aquaculture
5.5. Other Livestock
6. Asia-Pacific Eubiotics Market Outlook - by Application
6.1. Gut Health
6.2. Immunity
6.3. Yield Management
6.4. Other Applications
7. Asia-Pacific Eubiotics Market Outlook - by End-User
7.1. Animals
7.2. Humans
8. Asia-Pacific Eubiotics Market – Regional Outlook
8.1. China
8.2. Japan
8.3. India
8.4. South Korea
8.5. Asean Countries
8.6. Australia & New Zealand
8.7. Rest of Asia-Pacific
9. Competitive Landscape
9.1. Anpario plc
9.2. Archer Daniels Midland
9.3. Basf Se
9.4. Behn Meyer Group
9.5. Beneo GmbH
9.6. Cargill Inc
9.7. Chr Hansen Holding as
9.8. Dupont De Nemours Inc
9.9. Kemin Industries Inc
9.10. Koninklijke Dsm Nv
9.11. Lallemand Inc
9.12. Lesaffre
9.13. Neospark Drugs and Chemicals Private Limited
9.14. Novus International Inc
9.15. Yara International Asa
10. Research Methodology & Scope
10.1. Research Scope & Deliverables
10.2. Sources of Data
10.3. Research Methodology List of Tables
Table 1: Asia-Pacific Eubiotics Market, by Country, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Countries With the Highest Annual Meat Consumption
Table 4: Major Livestock Diseases in the World
Table 5: Asia-Pacific Eubiotics Market, by Type, 2021-2028 (In $ Million)
Table 6: Asia-Pacific Eubiotics Market, by Form, 2021-2028 (In $ Million)
Table 7: Asia-Pacific Eubiotics Market, by Livestock, 2021-2028 (In $ Million)
Table 8: Asia-Pacific Eubiotics Market, by Application, 2021-2028 (In $ Million)
Table 9: Asia-Pacific Eubiotics Market, by End-User, 2021-2028 (In $ Million)
Table 10: Asia-Pacific Eubiotics Market, by Country, 2021-2028 (In $ Million)
List of Figures
Figure 1: Market Attractiveness Index
Figure 2: Asia-Pacific Eubiotics Market, by Type, 2020 & 2028 (In %)
Figure 3: Asia-Pacific Eubiotics Market, by Probiotics, 2021-2028 (In $ Million)
Figure 4: Asia-Pacific Eubiotics Market, by Organic Acid, 2021-2028 (In $ Million)
Figure 5: Asia-Pacific Eubiotics Market, by Prebiotics, 2021-2028 (In $ Million)
Figure 6: Asia-Pacific Eubiotics Market, by Essential Oils, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Eubiotics Market, by Form, 2020 & 2028 (In %)
Figure 8: Asia-Pacific Eubiotics Market, by Dry, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Eubiotics Market, by Liquid, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Eubiotics Market, by Livestock, 2020 & 2028 (In %)
Figure 11: Asia-Pacific Eubiotics Market, by Swine, 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Eubiotics Market, by Poultry, 2021-2028 (In $ Million)
Figure 13: Asia-Pacific Eubiotics Market, by Ruminants, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Eubiotics Market, by Aquaculture, 2021-2028 (In $ Million)
Figure 15: Asia-Pacific Eubiotics Market, by Other Livestock, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Eubiotics Market, by Application, 2020 & 2028 (In %)
Figure 17: Asia-Pacific Eubiotics Market, by Gut Health, 2021-2028 (In $ Million)
Figure 18: Asia-Pacific Eubiotics Market, by Immunity, 2021-2028 (In $ Million)
Figure 19: Asia-Pacific Eubiotics Market, by Yield Management, 2021-2028 (In $ Million)
Figure 20: Asia-Pacific Eubiotics Market, by Other Applications, 2021-2028 (In $ Million)
Figure 21: Asia-Pacific Eubiotics Market, by End-User, 2020 & 2028 (In %)
Figure 22: Asia-Pacific Eubiotics Market, by Animals, 2021-2028 (In $ Million)
Figure 23: Asia-Pacific Eubiotics Market, by Humans, 2021-2028 (In $ Million)
Figure 24: Asia-Pacific Eubiotics Market, Regional Outlook, 2020 & 2028 (In %)
Figure 25: China Eubiotics Market 2021-2028 (In $ Million)
Figure 26: Japan Eubiotics Market 2021-2028 (In $ Million)
Figure 27: India Eubiotics Market 2021-2028 (In $ Million)
Figure 28: South Korea Eubiotics Market 2021-2028 (In $ Million)
Figure 29: Asean Countries Eubiotics Market 2021-2028 (In $ Million)
Figure 30: Australia & New Zealand Eubiotics Market 2021-2028 (In $ Million)
Figure 31: Rest of Asia-Pacific Eubiotics Market 2021-2028 (In $ Million)
Companies Mentioned
A selection of companies mentioned in this report includes:
- Anpario plc
- Archer Daniels Midland
- Basf Se
- Behn Meyer Group
- Beneo GmbH
- Cargill Inc
- Chr Hansen Holding as
- Dupont De Nemours Inc
- Kemin Industries Inc
- Koninklijke Dsm Nv
- Lallemand Inc
- Lesaffre
- Neospark Drugs and Chemicals Private Limited
- Novus International Inc
- Yara International Asa
Methodology
LOADING...
